We are live on ! Find out more
PR

Payden & Rygel Portfolio holdings

AUM $1.3B
1-Year Est. Return 28.32%
This Fund
S&P 500
This Quarter Est. Return
+9.64%
1 Year Est. Return
+28.32%
3 Year Est. Return
+89.13%
5 Year Est. Return
+123.15%
10 Year Est. Return
+353.66%
AUM
$1.21B
AUM Growth
-$1.88M
Cap. Flow
-$98.4M
Cap. Flow %
-8.16%
Top 10 Hldgs %
29.75%
Holding
126
New
13
Increased
20
Reduced
44
Closed
13

Top Buys

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$17.9M
2
VLO icon
Valero Energy
VLO
+$16.7M
3
ADI icon
Analog Devices
ADI
+$16.4M
4
MRK icon
Merck
MRK
+$16M
5
CVX icon
Chevron
CVX
+$15.3M

Top Sells

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$25.9M
2
AJG icon
Arthur J. Gallagher & Co
AJG
+$18.1M
3
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$15.9M
4
DHR icon
Danaher
DHR
+$15.6M
5
HCA icon
HCA Healthcare
HCA
+$15.5M

Sector Composition

Rank Sector Weight
1 Financials 19.47%
2 Technology 14.69%
3 Healthcare 11.02%
4 Industrials 9.65%
5 Communication Services 7.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VICI icon
101
VICI Properties
VICI
$29.4B
$207K 0.02%
6,360
– –
GNMA icon
102
iShares GNMA Bond ETF
GNMA
$422M
$202K 0.02%
4,553
– –
DELL icon
103
Dell
DELL
$283B
$198K 0.02%
1,400
– –
DLR icon
104
Digital Realty Trust
DLR
$73.7B
$190K 0.02%
1,100
-9,300
-89% -$1.59M
CMCSA icon
105
Comcast
CMCSA
$79.1B
$181K 0.02%
5,770
– –
ARES icon
106
Ares Management
ARES
$28.5B
$176K 0.01%
1,100
– –
AR icon
107
Antero Resources
AR
$10.9B
$131K 0.01%
3,910
– –
PBR icon
108
Petrobras
PBR
$121B
$129K 0.01%
10,210
– –
CB icon
109
Chubb
CB
$140B
$113K 0.01%
400
-35,800
-99% -$9.85M
EXE
110
Expand Energy Corp
EXE
$21.9B
$91K 0.01%
853
– –
KRE icon
111
State Street SPDR S&P Regional Banking ETF
KRE
$4.86B
$26K ﹤0.01%
406
– –
ARCC icon
112
Ares Capital
ARCC
$13.5B
$24K ﹤0.01%
1,160
– –
PFE icon
113
Pfizer
PFE
$140B
$10K ﹤0.01%
380
-24,300
-98% -$600K
AMGN icon
114
Amgen
AMGN
$203B
– –
-5,300
Closed -$1.48M
BA icon
115
Boeing
BA
$165B
– –
-3,200
Closed -$670K
BRK.B icon
116
Berkshire Hathaway Class B
BRK.B
$1.07T
– –
-32,800
Closed -$15.9M
DAL icon
117
Delta Air Lines
DAL
$55.9B
– –
-19,300
Closed -$949K
HCA icon
118
HCA Healthcare
HCA
$84.8B
– –
-40,500
Closed -$15.5M
LIN icon
119
Linde
LIN
$237B
– –
-25,700
Closed -$12.1M
SCI icon
120
Service Corp International
SCI
$11.4B
– –
-129,700
Closed -$10.6M
SPYM
121
State Street SPDR Portfolio S&P 500 ETF
SPYM
$159B
– –
-485
Closed -$35K
UNH icon
122
UnitedHealth
UNH
$382B
– –
-34,600
Closed -$10.8M
VLY icon
123
Valley National Bancorp
VLY
$7.93B
– –
-483
Closed -$4K
MMP
124
DELISTED
Magellan Midstream Partners, L.P.
MMP
– –
-15,600
Closed -$1.08M
NHP
125
DELISTED
NATIONWIDE HEALTH PROPERTIES
NHP
– –
-3,900
Closed -$165K
1 2 3 4
5

Similar funds

GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
PWP
Private Wealth Partners Mill Valley, California $1.3B AUM 26.2% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
CCFM
Clear Creek Financial Management Silverdale, Washington $1.3B AUM 20.31% 1-Year Est. Return

Payden & Rygel's Q3 2025 Portfolio in Review

As of Q3 2025, Payden & Rygel held 126 positions worth $1.21B, down 0.16% from $1.21B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Payden & Rygel withdrew a net $98.4M in Q3 2025, closing 13 positions and reducing 44 holdings. Its most notable exit was Berkshire Hathaway Class B, an estimated $15.9M position sold in full.

By sector, the portfolio is most concentrated in Financials at 19% of assets, down from 26% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Payden & Rygel opened a new position in CVS Health worth $19.7M.

  • Payden & Rygel's largest Q3 2025 buy was CVS Health: 261,500 shares worth $19.7M.
  • Payden & Rygel added most to Merck in Q3 2025, an estimated $16M increase.
  • Payden & Rygel's biggest Q3 2025 reduction was ExxonMobil, cutting an estimated $25.9M.
  • Payden & Rygel fully exited Berkshire Hathaway Class B in Q3 2025, selling an estimated $15.9M.
  • Payden & Rygel's ten largest holdings make up 30% of its $1.21B portfolio in Q3 2025.
  • Payden & Rygel opened 13 new positions and closed 13 in Q3 2025.
  • Payden & Rygel's portfolio value fell 0.16% quarter-over-quarter to $1.21B.

Based on Payden & Rygel's 13F filing for Q3 2025, filed 10 Nov 2025.